Why autoimmune diseases mostly strike women and are often misdiagnosed
-
By
-
Lauran Neergaard
-
November 6, 2025
-
0 min
Clinical Scorecard: Understanding the Gender Disparity and Diagnostic Challenges in Autoimmune Diseases
At a Glance
| Category | Detail |
|---|---|
| Condition | Autoimmune diseases are chronic conditions where the immune system attacks the body's own cells and tissues, affecting various organs and systems. |
| Key Mechanisms | Loss of immune tolerance leads to immune cells or antibodies attacking self-tissues; triggers include genetic susceptibility combined with environmental factors like infections or pollutants. |
| Target Population | Predominantly women (about 80% of cases), especially young women; men and children can also be affected; certain ethnic groups have higher risks for specific diseases. |
| Care Setting | Diagnosis and management often require multiple specialists and tests over extended periods; care occurs in outpatient and specialty clinical settings. |
Key Highlights
- Autoimmune diseases encompass over 100 disorders with diverse symptoms affecting joints, muscles, organs, and the brain.
- Diagnosis is challenging due to vague, overlapping symptoms and requires ruling out other causes with antibody testing and clinical evaluation.
- Women are disproportionately affected, possibly due to hormonal influences and X chromosome abnormalities; environmental triggers like Epstein-Barr virus contribute to disease onset.
Guideline-Based Recommendations
Diagnosis
- Diagnosis centers on clinical symptoms and exclusion of other diseases.
- Multiple blood tests to detect autoantibodies are used to support diagnosis.
- Updated guidelines and education aim to streamline diagnosis, e.g., for multiple sclerosis and autoimmune encephalitis.
Management
- Treatment is lifelong and often involves immunosuppressive drugs, including steroids and targeted molecular therapies.
- Emerging therapies like CAR-T are under clinical trial to reprogram the immune system.
- Management is often trial and error due to disease complexity and variability.
Monitoring & Follow-up
- Patients require ongoing monitoring for disease flares and organ involvement.
- Regular assessment is needed to balance treatment efficacy and side effects.
Risks
- Immunosuppressive treatments carry risks of infections and cancer.
- Delayed diagnosis can lead to irreversible organ damage.
Patient & Prescribing Data
Patients with various autoimmune diseases, predominantly women but inclusive of all ages and ethnicities.
Treatment approaches are evolving from broad immunosuppression to targeted therapies; clinical trials are exploring immune system reprogramming to improve outcomes.
Clinical Best Practices
- Maintain high suspicion for autoimmune diseases in patients with vague or overlapping symptoms.
- Use a combination of clinical evaluation and antibody testing for diagnosis.
- Educate clinicians on updated diagnostic criteria to reduce delays.
- Consider patient-specific factors including gender, ethnicity, and disease subtype in management.
- Monitor patients closely for disease flares and treatment side effects.
- Stay informed about emerging therapies and clinical trials.
References
- AP Be Well Coverage on Autoimmune Diseases
- National MS Society Guidelines
- Stanford University Research on Epstein-Barr Virus and Lupus
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
